Thymic carcinoma outcomes and prognosis: results of an international analysis.

@article{Ahmad2015ThymicCO,
  title={Thymic carcinoma outcomes and prognosis: results of an international analysis.},
  author={Usman A. Ahmad and Xiaopan Yao and Frank C. Detterbeck and James P. Huang and Alberto Antonicelli and Pier Luigi Filosso and Enrico Ruffini and William D Travis and David R. Jones and Yilei Zhan and Marco Lucchi and Andreas Rimner},
  journal={The Journal of thoracic and cardiovascular surgery},
  year={2015},
  volume={149 1},
  pages={95-100, 101.e1-2}
}
OBJECTIVES The objectives of this collaborative study were to characterize patients with thymic carcinoma, their treatment patterns, and association with overall survival (OS) and recurrence-free survival (RFS). METHODS Clinical, pathologic, treatment, and follow-up information were analyzed. OS and RFS were the primary outcome measures. RESULTS In 1042 cases of thymic carcinoma, 42 (5%) patients had pathologic Masaoka stage I, 138 (17%) had stage II, 370 (45%) had stage III, and 274 (33… CONTINUE READING